HIV and Stem Cell Transplantation

Ignacio A. Echenique, George E. Nelson, Valentina Stosor, Christine M. Durand*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


In human immunodeficiency virus (HIV)-infected persons, the incidence of hematologic malignancies, including leukemia and lymphoma, is increased despite the use of successful antiretroviral therapy. Hematopoietic stem cell transplantation (SCT) is emerging as a safe and effective therapy for HIV-infected persons with hematologic malignancies. Management of these patients is complicated by drug–drug interactions involving antiretroviral therapy (ART) that may impact conditioning agent efficacy and metabolism of immunosuppressive medications and potentiate drug toxicities. As such, optimal strategies for ART remain controversial. We discuss recent advances, controversies, and future directions related to SCT in HIV-infected persons, including the investigation of allogeneic SCT as a strategy for HIV cure.

Original languageEnglish (US)
Article number424
Pages (from-to)1-10
Number of pages10
JournalCurrent Infectious Disease Reports
Issue number9
StatePublished - Sep 1 2014


  • AIDS
  • Allogeneic stem cell transplantation
  • Antiretroviral therapy
  • Autologous stem cell transplantation
  • Bone marrow transplantation
  • GVHD
  • HIV
  • HIV cure
  • HIV eradication
  • HIV reservoir
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Stem cell transplantation

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'HIV and Stem Cell Transplantation'. Together they form a unique fingerprint.

Cite this